{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-01-23&answer.answeringMemberConstituency=Winchester", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2018-01-23&answer.answeringMemberConstituency=Winchester", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-01-23&answer.answeringMemberConstituency=Winchester&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-01-23&_page=0&answer.answeringMemberConstituency=Winchester", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-01-23&answer.answeringMemberConstituency=Winchester", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-01-23&answer.answeringMemberConstituency=Winchester", "items" : [{"_about" : "http://data.parliament.uk/resources/828571", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/828571/answer", "answerText" : {"_value" : "
The United Kingdom National Screening Committee (UK NSC) offers screening to an asymptomatic population for conditions which have been evaluated against their robust and extensive criteria. The UK NSC last reviewed the evidence to screen for ovarian cancer in 2016 and recommended that population screening should not be offered. Research has shown that screening women under the age of 50 is less effective especially when they have not entered into the menopause phase.<\/p>
<\/p>
There are currently no plans to offer screening to women over the age of 30 for either ovarian or breast cancer.<\/p>
<\/p>
A proposal to change an existing programme, such as age to the breast screening programme would follow the UK NSC\u2019s evidence review process. Information about this process is available at:<\/p>
<\/p>
https://www.gov.uk/government/publications/uk-nsc-evidence-review-process<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-01-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-01-29T17:00:31.75Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-01-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Screening"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if his Department will take steps to introduce testing for all women over 30 years old for early signs of (a) ovarian and (b) breast cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/473", "label" : {"_value" : "Biography information for Sir Mark Hendrick"}
}
, "tablingMemberConstituency" : {"_value" : "Preston"}
, "tablingMemberPrinted" : [{"_value" : "Sir Mark Hendrick"}
], "uin" : "124244"}
, {"_about" : "http://data.parliament.uk/resources/828693", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/828693/answer", "answerText" : {"_value" : " Information on how many hospital admissions caused by Fentanyl misuse there were in 2016 and 2017 is not held centrally.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-01-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-01-31T13:52:36.08Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-01-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Fentanyl"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many hospital admissions caused by Fentanyl misuse there were in (a) 2016 and (b) 2017.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4456", "label" : {"_value" : "Biography information for Jeff Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Manchester, Withington"}
, "tablingMemberPrinted" : [{"_value" : "Jeff Smith"}
], "uin" : "124346"}
, {"_about" : "http://data.parliament.uk/resources/828793", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/828793/answer", "answerText" : {"_value" : " The National Institute for Health and Care Excellence guidance Chronic kidney disease in adults: assessment and management, updated in July 2014, sets out best practice for clinicians in the diagnosis and management of chronic kidney disease (CKD). The guidance covers identification and monitoring of patients at risk; pharmacological management and referral where appropriate, and aims to ensure patients remain healthy and avoid kidney failure, if possible. The guidance can be found at the following link:<\/p> <\/p>